Pharmafile Logo
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • - PMLiVE
  • Communiqué 53 Cover Image

Pepperl+Fuchs GB Limited

Pepperl+Fuchs is a leading developer and manufacturer of electronic sensors and components for the global automation market. Continuous innovation, enduring quality, and steady growth guarantees continued success, since more than 60 years. Pepperl+Fuchs employs 5,200 people worldwide and has manufacturing facilities in Germany, USA, Singapore, Hungary, Indonesia and Vietnam, most of them ISO 9001 certified.

This is a FREE LISTING on PMHUB

Below are full profiles from other companies in related areas

No items found

Company Details

Pepperl+Fuchs GB Limited
77 Ripponden Road, Oldham, Lancashire, OL1 4EL, United Kingdom
+44 (0)161 6336431
Contact Pepperl+Fuchs GB Limited
Website

 Latest Content from PMHub 

Smart connections with a human touch

White Papers and Resources | January 26, 2017 | Blue Latitude Health

Simon Young, Director at Blue Latitude Health, discusses how advances in technology are influencing the future of the expert-patient relationship and why healthcare businesses must evaluate how best to support...

AN ADVOCACY Rx FOR PROGRESS IN MENTAL HEALTH

White Papers and Resources | January 25, 2017 | Syneos Health®

Through sustained partnerships between advocacy and industry, the US and Europe can overcome barriers to care.

Mental Health Patient Advocacy Groups in EU Say Strong Partnerships with Government and Industry Can Ensure Forward Progress

Press Releases | January 25, 2017 | Syneos Health®

New Report from inVentiv Health Examines Mental Health Advocacy Wish Lists and Priorities for Reform

Cool heads in a crisis?

White Papers and Resources | January 25, 2017 | Inizio

Understanding the role pharmaceutical companies can play in fighting today’s global health pandemics

Biosimilars: Bringing patients into the conversation

White Papers and Resources | January 25, 2017 | Inizio

Published in eyeforpharma January 2017 by Mariel Metcalfe

Access and elimination: the future of DAAs in hepatitis C

White Papers and Resources | January 25, 2017 | Inizio

Published in Pharmaphorum January 2017

EphMRA One Day Meeting

White Papers and Resources | January 25, 2017 | Inizio

We are delighted to be attending and presenting a paper at the EphMRA one day meeting on Tuesday 21st February, in London

Video: Segmentation research

White Papers and Resources | January 25, 2017 | Inizio

Why would a pharma company want to carry out a segmentation study? What are some of the challenges? Head of Business Analytics Tom Nolte and Associate Director Dr Marianne Jaeger...

Pharmaceutical Market Research Conference 2017

White Papers and Resources | January 25, 2017 | Inizio

We are delighted to be exhibiting and presenting a paper at the Pharmaceutical Market Research Conference 1-2 February in Parsippany, NJ.

Shifting perceptions of the use of probiotics in IBS Management

White Papers and Resources | January 25, 2017 | Inizio

Our client was planning to launch an over-the-counter (OTC) probiotics product for the purposes of improving IBS management and wanted to understand current perceptions, practices and usage amoungst a range...